Search | VHL Search Portal

1.

Atezolizumab plus bevacizumab and chemotherapy for metastatic, persistent, or recurrent cervical cancer (BEATcc): a randomised, open-label, phase 3 trial.

Oaknin, Ana; Gladieff, Laurence; Martínez-García, Jerónimo; Villacampa, Guillermo; Takekuma, Munetaka; De Giorgi, Ugo; Lindemann, Kristina; Woelber, Linn; Colombo, Nicoletta; Duska, Linda; Leary, Alexandra; Godoy-Ortiz, Ana; Nishio, Shin; Angelergues, Antoine; Rubio, Maria Jesús; Fariñas-Madrid, Lorena; Yamaguchi, Satoshi; Lorusso, Domenica; Ray-Coquard, Isabelle; Manso, Luis; Joly, Florence; Alarcón, Jesús; Follana, Philippe; Romero, Ignacio; Lebreton, Coriolan; Pérez-Fidalgo, J Alejandro; Yunokawa, Mayu; Dahlstrand, Hanna; D'Hondt, Véronique; Randall, Leslie M.

Lancet ; 403(10421): 31-43, 2024 Jan 06.

Article in English | MEDLINE | ID: mdl-38048793

2.

Top advances of the year: Cervical cancer.

Duska, Linda R; Podwika, Sarah E; Randall, Leslie M.

Cancer ; 2024 Apr 23.

Article in English | MEDLINE | ID: mdl-38651760

3.

Cervical cancer treatment update: A Society of Gynecologic Oncology clinical practice statement.

Girda, Eugenia; Randall, Leslie M; Chino, Fumiko; Monk, Bradley J; Farley, John H; O'Cearbhaill, Roisin E.

Gynecol Oncol ; 179: 115-122, 2023 Dec.

Article in English | MEDLINE | ID: mdl-37980766

4.

Niraparib and dostarlimab for the treatment of recurrent platinum-resistant ovarian cancer: results of a Phase II study (MOONSTONE/GOG-3032).

Randall, Leslie M; O'Malley, David M; Monk, Bradley J; Coleman, Robert L; Gaillard, Stephanie; Adams, Sarah; Duska, Linda R; Dalton, Heather; Holloway, Robert W; Huang, Marilyn; Chon, Hye Sook; Cloven, Noelle G; ElNaggar, Adam C; O'Cearbhaill, Roisin E; Waggoner, Steven; Tarkar, Aarti; Striha, Alina; Nelsen, Linda M; Baines, Amanda; Samnotra, Vivek; Konstantinopoulos, Panagiotis A.

Gynecol Oncol ; 178: 161-169, 2023 Nov.

Article in English | MEDLINE | ID: mdl-37890345

5.

The GOG partners: A program for industry sponsored clinical trials in gynecologic oncology within the GOG foundation.

Monk, Bradley J; Coleman, Robert L; Herzog, Thomas J; Moore, Kathleen N; O'Malley, David M; Randall, Leslie M; Slomovitz, Brian M; Eskander, Ramez; Pothuri, Bhavana; Reese, Laura L; Mannel, Robert S; Copeland, Larry J.

Gynecol Oncol ; 162(1): 203-209, 2021 07.

Article in English | MEDLINE | ID: mdl-33722417

6.

Phase II study of the safety and efficacy of the anti-PD-1 antibody balstilimab in patients with recurrent and/or metastatic cervical cancer.

O'Malley, David M; Oaknin, Ana; Monk, Bradley J; Selle, Frédéric; Rojas, Carlos; Gladieff, Laurence; Berton, Dominique; Leary, Alexandra; Moore, Kathleen N; Estevez-Diz, Maria D P; Hardy-Bessard, Anne-Claire; Alexandre, Jérôme; Opperman, Christina P; de Azevedo, Carla Rameri A S; Randall, Leslie M; Feliu, Waldo Ortuzar; Ancukiewicz, Marek; Ray-Coquard, Isabelle.

Gynecol Oncol ; 163(2): 274-280, 2021 11.

Article in English | MEDLINE | ID: mdl-34452745

7.

RaPiDS (GOG-3028): randomized Phase II study of balstilimab alone or in combination with zalifrelimab in cervical cancer.

O'Malley, David M; Randall, Leslie M; Jackson, Camille Gunderson; Coleman, Robert L; Hays, John L; Moore, Kathleen N; Naumann, R Wendel; Rocconi, Rodney P; Slomovitz, Brian M; Tewari, Krishnansu S; Ancukiewicz, Marek; Feliu, Waldo Ortuzar; Monk, Bradley J.

Future Oncol ; 17(26): 3433-3443, 2021 Sep.

Article in English | MEDLINE | ID: mdl-34409858

8.

Bevacizumab plus fosbretabulin in recurrent ovarian cancer: Overall survival and exploratory analyses of a randomized phase II NRG oncology/gynecologic oncology group study.

Tewari, Krishnansu S; Sill, Michael W; Coleman, Robert L; Aghajanian, Carol; Mannel, Robert; DiSilvestro, Paul A; Powell, Matthew; Randall, Leslie M; Farley, John; Rubin, Stephen C; Monk, Bradley J.

Gynecol Oncol ; 159(1): 79-87, 2020 10.

Article in English | MEDLINE | ID: mdl-32723679

9.

Niraparib in the treatment of previously treated advanced ovarian, fallopian tube or primary peritoneal cancer.

Rimel, B J; Dockery, Lauren; Randall, Leslie M; Moore, Kathleen.

Future Oncol ; 16(33): 2701-2711, 2020 Nov.

Article in English | MEDLINE | ID: mdl-32880196

10.

Prevalence and predictors of HIV screening in invasive cervical cancer: a 10 year cohort study.

Alldredge, Jill; Leaf, Marie-Claire; Patel, Priya; Coakley, Katherine; Longoria, Teresa; McLaren, Christine; Randall, Leslie M.

Int J Gynecol Cancer ; 30(6): 772-776, 2020 06.

Article in English | MEDLINE | ID: mdl-32156714

11.

Ovarian Cancer Maintenance: Practice-Changing Data Calls for Changing Practice.

Randall, Leslie M; Birrer, Michael J; Herzog, Thomas J.

Oncologist ; 24(5): 576-579, 2019 05.

Article in English | MEDLINE | ID: mdl-30894410

12.

A phase II, multicenter, open-label trial of OTL38 injection for the intra-operative imaging of folate receptor-alpha positive ovarian cancer.

Randall, Leslie M; Wenham, Robert M; Low, Philip S; Dowdy, Sean C; Tanyi, Janos L.

Gynecol Oncol ; 155(1): 63-68, 2019 10.

Article in English | MEDLINE | ID: mdl-31362825

13.

It's time to warm up to hyperthermic intraperitoneal chemotherapy for patients with ovarian cancer.

Zivanovic, Oliver; Chi, Dennis S; Filippova, Olga; Randall, Leslie M; Bristow, Robert E; O'Cearbhaill, Roisin E.

Gynecol Oncol ; 151(3): 555-561, 2018 12.

Article in English | MEDLINE | ID: mdl-30249527

14.

Multi-disciplinary summit on genetics services for women with gynecologic cancers: A Society of Gynecologic Oncology White Paper.

Randall, Leslie M; Pothuri, Bhavana; Swisher, Elizabeth M; Diaz, John P; Buchanan, Adam; Witkop, Catherine T; Bethan Powell, C; Smith, Ellen Blair; Robson, Mark E; Boyd, Jeff; Coleman, Robert L; Lu, Karen.

Gynecol Oncol ; 146(2): 217-224, 2017 08.

Article in English | MEDLINE | ID: mdl-28596016

15.

Practice changing cervical cancer clinical trials.

Pothuri, Bhavana; Eskander, Ramez N; Randall, Leslie M; O'Malley, David M; Slomovitz, Brian; Moore, Kathleen N; Herzog, Thomas J; Coleman, Robert L; Copeland, Larry J; Monk, Bradley J.

Gynecol Oncol ; 165(3): 410-412, 2022 06.

Article in English | MEDLINE | ID: mdl-35461731

16.

The role of immunotherapy in recurrent or metastatic cervical cancer.

Randall, Leslie M.

Clin Adv Hematol Oncol ; 20(7): 435-437, 2022 07.

Article in English | MEDLINE | ID: mdl-35802874

17.

The genetic prediction of risk for gynecologic cancers.

Randall, Leslie M; Pothuri, Bhavana.

Gynecol Oncol ; 141(1): 10-6, 2016 Apr.

Article in English | MEDLINE | ID: mdl-27016223

18.

Expression Patterns of the Wnt Pathway Inhibitors Dickkopf3 and Secreted Frizzled-Related Proteins 1 and 4 in Endometrial Endometrioid Adenocarcinoma: An NRG Oncology/Gynecologic Oncology Group Study.

Eskander, Ramez N; Ali, Shamshad; Dellinger, Thanh; Lankes, Heather A; Randall, Leslie M; Ramirez, Nilsa C; Monk, Bradley J; Walker, Joan L; Eisenhauer, Eric; Hoang, Bang H.

Int J Gynecol Cancer ; 26(1): 125-32, 2016 Jan.

Article in English | MEDLINE | ID: mdl-26397159

19.

HIPEC in ovarian cancer: hip or hype?

Randall, Leslie M.

Clin Adv Hematol Oncol ; 19(8): 497-499, 2021 Aug.

Article in English | MEDLINE | ID: mdl-34411068

20.

Socioeconomic status as a predictor of adherence to treatment guidelines for early-stage ovarian cancer.

Hodeib, Melissa; Chang, Jenny; Liu, Fong; Ziogas, Argyrios; Dilley, Sarah; Randall, Leslie M; Anton-Culver, Hoda; Bristow, Robert E.

Gynecol Oncol ; 138(1): 121-7, 2015 Jul.

Article in English | MEDLINE | ID: mdl-25913132

VHL Search Portal

Information and Knowledge for Health

Config filters

Your selection (0)

Export format:

Export: